According to gulfnews.com, doctors at Tawam Hospital in Abu Dhabi have achieved an astonishing milestone by successfully treating rare inflammatory diseases for the first time in the United Arab Emirates. This hospital, part of SEHA under PureHealth, has utilized the biologic drug Rilonacept to help two young Emirati patients recover from conditions that were previously resistant to treatment. This innovative treatment, used for adult-onset Still's disease (AOSD) and recurrent idiopathic pericarditis, has significantly alleviated severe symptoms such as recurrent fever, pain, and shortness of breath. Dr. Khaled Abdullah Alnaqbi, head of rheumatology at Tawam Hospital, regarded this success as a testament to the hospital's growing role as a leading center for complex autoimmune and rheumatic diseases. Dr. Dalaal Almansoori, executive medical director, also emphasized that providing advanced treatments locally showcases Abu Dhabi's capability to deliver patient-centered innovations on a global scale. This achievement has not only improved the quality of life for patients but also reflects the ongoing efforts of the United Arab Emirates in advancing science and technology in the medical field. The Abu Dhabi Department of Health has facilitated rapid access to innovative treatments for patients by expediting drug approvals. This significant accomplishment has brought new hope for patients and their families and highlights the medical capabilities within the country. For more images and additional information, please refer to the source of the news.